These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27931155)

  • 1. Prenatal paradox: an integrative review of women's experiences with prenatal screening for fetal aneuploidy and neural tube defects.
    Shea TL
    Contemp Nurse; 2017 Apr; 53(2):235-261. PubMed ID: 27931155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitating autonomous, confident and satisfying choices: a mixed-method study of women's choice-making in prenatal screening for common aneuploidies.
    Chen A; Tenhunen H; Torkki P; Peltokorpi A; Heinonen S; Lillrank P; Stefanovic V
    BMC Pregnancy Childbirth; 2018 May; 18(1):119. PubMed ID: 29720125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for fetal aneuploidy and neural tube defects.
    Driscoll DA; Gross SJ;
    Genet Med; 2009 Nov; 11(11):818-21. PubMed ID: 19915395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's decision making regarding prenatal screening for fetal aneuploidy: A qualitative comparison between 2003 and 2016.
    van Bruggen MJ; Henneman L; Timmermans DRM
    Midwifery; 2018 Sep; 64():93-100. PubMed ID: 29990629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome.
    Reid B; Sinclair M; Barr O; Dobbs F; Crealey G
    Soc Sci Med; 2009 Dec; 69(11):1561-73. PubMed ID: 19783085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second trimester maternal serum screening for fetal open neural tube defects and aneuploidy.
    Driscoll DA;
    Genet Med; 2004; 6(6):540-1. PubMed ID: 15545752
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does offering prenatal screening influence pregnant women's attitudes regarding prenatal testing?
    Kleinveld JH; van den Berg M; van Eijk JT; van Vugt JM; van der Wal G; Timmermans DR
    Community Genet; 2008; 11(6):368-74. PubMed ID: 18690005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health literacy and patient understanding of screening tests for aneuploidy and neural tube defects.
    Cho RN; Plunkett BA; Wolf MS; Simon CE; Grobman WA
    Prenat Diagn; 2007 May; 27(5):463-7. PubMed ID: 17345585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian women's attitudes toward noninvasive prenatal testing of fetal DNA in maternal plasma (.).
    Pariente G; Hasan L; Gadot Y; De Souza LR; Lebovic G; Berger H
    J Matern Fetal Neonatal Med; 2016 Dec; 29(24):4008-14. PubMed ID: 26940147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening for neural tube defects.
    Rajesh R; Thomas SV
    Natl Med J India; 2001; 14(6):343-6. PubMed ID: 11804365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of experiential knowledge on prenatal screening and testing decisions.
    Etchegary H; Potter B; Howley H; Cappelli M; Coyle D; Graham I; Walker M; Wilson B
    Genet Test; 2008 Mar; 12(1):115-24. PubMed ID: 18307384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneuploidy with neural tube defects: another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein.
    Drugan A; Johnson MP; Dvorin E; Moody J; Krivchenia EL; Schwartz D; Evans MI
    Fetal Ther; 1989; 4(2-3):88-92. PubMed ID: 2484814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perception of risk: informed choice in prenatal testing for foetal aneuploidy.
    Choolani M; Biswas A
    Singapore Med J; 2012 Oct; 53(10):633-6; quiz 637. PubMed ID: 23112012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for neural tube defects: perceptions of potential recipients.
    Howard SB; Headings VE
    Soc Biol; 1991; 38(3-4):258-65. PubMed ID: 1801206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women as moral pioneers? Experiences of first trimester antenatal screening.
    Williams C; Sandall J; Lewando-Hundt G; Heyman B; Spencer K; Grellier R
    Soc Sci Med; 2005 Nov; 61(9):1983-92. PubMed ID: 15899542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Sep; 155(5):349. PubMed ID: 1832734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.